Nephros Inc (NEPH) — 10-Q Filings

10-Q Filings (6)

• Nephros Swings to Profit on Strong Revenue Growth, Cash Flow Positive — Nov 6, 2025 Risk: medium
  NEPHROS INC reported a significant financial turnaround for the nine months ended September 30, 2025, achieving a net income of $1.132 million, a substantial im
• Nephros Q2 Revenue Jumps 30% on Strong Product Sales — Aug 7, 2025 Risk: medium
  NEPHROS INC reported a significant increase in product revenue for the three months ended June 30, 2025, reaching $2.8 million, up from $2.1 million in the prio
• Nephros Inc. Files Q1 2025 10-Q — May 15, 2025 Risk: medium
  Nephros Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025
• Nephros Inc. Files Q3 2024 10-Q Report — Nov 14, 2024 Risk: low
  Nephros Inc. filed its 10-Q for the period ending September 30, 2024. The company, incorporated in Delaware and operating in the surgical and medical instrument
• Nephros Inc. Q2 Revenue Declines — Aug 8, 2024 Risk: medium
  Nephros Inc. filed its 10-Q for the period ending June 30, 2024. The company reported product revenues of $1.8 million for the second quarter of 2024, a decreas
• Nephros Inc. Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: low
  NEPHROS INC (NEPH) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Nephros Inc. filed its quarterly report (10-Q) on May 9, 2024, for the period en

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX